Your browser doesn't support javascript.
loading
Novel Aptamer Strategies in Combating Bacterial Infections: From Diagnostics to Therapeutics.
Ye, Zijian; Chen, Huaizhi; Weinans, Harrie; van der Wal, Bart; Rios, Jaqueline Lourdes.
Afiliação
  • Ye Z; Department of Orthopedics, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
  • Chen H; Department of Orthopedics, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
  • Weinans H; Department of Orthopedics, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
  • van der Wal B; Department of Biomechanical Engineering, Faculty of Mechanical Engineering, Delft University of Technology (TU Delft), 2628 CD Delft, The Netherlands.
  • Rios JL; Department of Orthopedics, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Pharmaceutics ; 16(9)2024 Aug 29.
Article em En | MEDLINE | ID: mdl-39339177
ABSTRACT
Bacterial infections and antimicrobial resistance are posing substantial difficulties to the worldwide healthcare system. The constraints of conventional diagnostic and therapeutic approaches in dealing with continuously changing infections highlight the necessity for innovative solutions. Aptamers, which are synthetic oligonucleotide ligands with a high degree of specificity and affinity, have demonstrated significant promise in the field of bacterial infection management. This review examines the use of aptamers in the diagnosis and therapy of bacterial infections. The scope of this study includes the utilization of aptasensors and imaging technologies, with a particular focus on their ability to detect conditions at an early stage. Aptamers have shown exceptional effectiveness in suppressing bacterial proliferation and halting the development of biofilms in therapeutic settings. In addition, they possess the capacity to regulate immune responses and serve as carriers in nanomaterial-based techniques, including radiation and photodynamic therapy. We also explore potential solutions to the challenges faced by aptamers, such as nuclease degradation and in vivo instability, to broaden the range of applications for aptamers to combat bacterial infections.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pharmaceutics Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Holanda País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pharmaceutics Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Holanda País de publicação: Suíça